Helping Veterans quit smoking during cancer care
Official title: Contingency Management for Veteran Smokers With or at Risk for Cancer
Run by VA Office of Research and Development · NCT06432985 · Data updated 2026-11-12
This study is testing a new program to help Veterans quit smoking while they are being screened or treated for lung cancer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 108 (estimated) |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 1 site (San Francisco, California) |
| Status | Recruiting |
| Started | January 29, 2025 |
| Main results expected | August 15, 2031 |
| Study ends | September 30, 2031 |
| Registry record updated | October 2, 2026 |
| Trial ID | NCT06432985 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are Veterans aged 18 and older who are eligible for VA healthcare and have received cancer monitoring or treatment within the past 24 months.
✕Probably not a fit
Patients who are not Veterans or those who do not speak English may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to evaluate the effectiveness of a Contingency Management (CM) program designed to assist Veterans in quitting smoking while undergoing lung cancer screening or treatment. The study will first develop a mobile CM protocol based on feedback from Veterans and healthcare staff through focus groups. Following this, a pilot study will test the feasibility of the mobile CM program combined with counseling and medication for 20 Veterans over five weeks. If successful, the findings will inform a larger randomized controlled trial comparing mobile CM to standard treatment.
Why it matters
Potential benefit: If successful, this program could significantly improve smoking cessation rates among Veterans, leading to better health outcomes and quality of life.
How similar studies have gone: Other studies have shown promise with similar behavioral interventions, suggesting that this approach could be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: In order to be eligible to participate in this study, an individual must meet all of the following criteria: * Human Subjects Involvement and Characteristics: This Proof of Concept and Clinical Trial has three stages. The Proof-of-Concept Phase (Years 1-2) includes a Focus Group phase (Year 1) in which the investigators will recruit both Veterans and non-Veterans (VA clinical staff); and a Pilot Study (Year 2) in which the investigators will recruit Veterans in LCS or cancer treatment at San Francisco VA Healthcare System (SFVAHCS). If the Pilot Study is successful, the investigators will recruit Veterans in lung cancer screening (LCS) or cancer treatment for the RCT (Years 3-6). * Focus Groups: For Focus Groups (Year 1), the investigators will recruit both Veterans and VA clinical staff at SFVAHCS. Veterans: * Veteran eligible for VA healthcare * English-speaking * Received SFVAHCS cancer monitoring or treatment or lung cancer screening (LCS) within the past 24 months * Active cigarette smoking within the past 24 months * Have access to Wi-Fi and a device that supports audio and video communication VA Clinical Staff: * Current member of clinical staff at the SFVAHCS * Have participated in the care of at least 5 VA cancer or LCS patients in the past 6 months Pilot Feasibility Study (Year 2) and Randomized Controlled Trial Inclusion criteria: * Veteran currently receiving medical care at SFVAHCS (at least one clinical visit same calendar year for cancer) * English-speaking * Current, active (same calendar year) enrollment in VA LCS, or current (same calendar year) diagnosis of cancer documented in the VA medical record, confirmed through medical record review * Current (past 30 days) cigarette smoking a minimum of 1 cigarette per day (average), assessed by Timeline Followback (TLFB)92, 99-101 * Open to receiving smoking cessation interventions Exclusion Criteria: Focus Groups: For Focus Groups (Year 1), the investigators will recruit both Veterans and VA clinical staff at SFVAHCS. Veterans: Exclusion criteria: Assessed by Co-PIs' medical record review: * Current severe, untreated mental illness (i.e., psychosis, bipolar disorder, and/or substance use disorder (SUD) and/or * Current (past 30 days) active suicidal/homicidal ideation or severe behavioral instability that would prevent participation * Never smokers or quit smoking for longer than 36 months prior to consent (4) no access to Wi-Fi or devices that support audio and video communication VA Clinical Staff: Exclusion Criteria: * Unable to commit approximately 45-60 minutes (approx. 30-60 mins focus group/interview and self-report questionnaires) Pilot Feasibility Study (Year 2) and Randomized Controlled Trial Exclusion Criteria: * An individual who meets any of the following criteria will be excluded from participation in this study: * Evaluated by investigative team medical record review and clinical assessment: * Psychotic disorders, bipolar disorder, neurocognitive disorder, substance use disorders, or other psychiatric or medical conditions judged by the PI to be unstable in the past 30 days, based on screening results and/or medical record review, including conditions for which large sums of money would be potentially destabilizing * Untreated, current, active problem gambling, assessed by medical record diagnosis and/ or Problem Gambling Severity Index (PGSI) score 8 * Metastatic cancer or enrollment in end of life/ palliative care * Unable to commit to time commitment required for participation * Currently pregnant or planning to become pregnant during the study (people of childbearing potential ages 18-55 who are pregnant or state that they plan to become pregnant during the study) * A suicide attempt or suicidal ideation with intent in the 30 days prior to enrollment * Concurrent enrollment in a tobacco cessation clinical trial
Where it's running
-
San Francisco VA Medical Center, San Francisco, CA
San Francisco, California, United States Recruiting
Study contacts
- Principal investigator: Ellen Herbst, MD — San Francisco VA Medical Center, San Francisco, CA
- Study coordinator: Ellen Herbst, MD
- Email: Ellen.Herbst@va.gov
- Phone: (415) 221-4810
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Personalized brain-targeted TMS for smoking cessation
A personalized brain-guided Transcranial Magnetic Stimulation (TMS) approach is tested against a standard TMS method to see if it better changes reward brain activity and reduces cravings and smoking in adults with tobacco use disorder.
-
Honest, Open, Proud for justice-involved veterans
This trial tests a peer-delivered stigma-reduction program for veterans with co-occurring mental health or substance use disorders who are involved with the justice system, to see if different delivery intensities help more veterans engage in care.
-
Olfactory function and decision-making in people with HIV and/or substance use
This study tests how the sense of smell relates to decision-making in adults with HIV, substance use, both, or neither.
-
Multilevel program to increase LDCT lung cancer screening and help African American smokers quit
This program will try combining low-dose CT screening with culturally tailored smoking-cessation support to help African American smokers who are eligible for LDCT quit and get screened.
-
TUBSIS 2.0 — an online program to help adults reduce or quit smoking and vaping
This program tests whether a free, anonymous, 4-week web-based course using mindfulness, self-compassion, and behavior-change techniques helps German-, English-, and Turkish-speaking adults who smoke or vape reduce or quit tobacco.
-
Impact of Menthol vs. Non-Menthol Cigarettes on Abuse Liability
This study tests whether menthol cigarettes have different abuse potential than non-menthol cigarettes in menthol cigarette users, using a within-subject design across lab sessions and daily diaries.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.